Please use a PC Browser to access Register-Tadawul
Get It
Phio Pharmaceuticals shares are trading higher after the company announced a comprehensive U.S. drug substance development services agreement for its lead compound PH-762.
Phio Pharmaceuticals Corp. PHIO | 1.08 1.07 | -0.92% -0.93% Pre |
